Dexcom (DXCM) Other Working Capital Changes (2016 - 2026)
Dexcom has reported Other Working Capital Changes over the past 17 years, most recently at -$51.0 million for Q1 2026.
- Quarterly Other Working Capital Changes fell 209.09% to -$51.0 million in Q1 2026 from the year-ago period, while the trailing twelve-month figure was -$19.7 million through Mar 2026, down 2914.29% year-over-year, with the annual reading at $14.8 million for FY2025, 155.17% up from the prior year.
- Other Working Capital Changes was -$51.0 million for Q1 2026 at Dexcom, down from $6.9 million in the prior quarter.
- Over five years, Other Working Capital Changes peaked at $97.9 million in Q1 2022 and troughed at -$51.0 million in Q1 2026.
- The 5-year median for Other Working Capital Changes is -$6.1 million (2023), against an average of $4.8 million.
- Year-over-year, Other Working Capital Changes skyrocketed 1525.81% in 2022 and then tumbled 1176.92% in 2023.
- A 5-year view of Other Working Capital Changes shows it stood at $50.4 million in 2022, then crashed by 112.1% to -$6.1 million in 2023, then tumbled by 31.15% to -$8.0 million in 2024, then skyrocketed by 186.25% to $6.9 million in 2025, then plummeted by 839.13% to -$51.0 million in 2026.
- Per Business Quant, the three most recent readings for DXCM's Other Working Capital Changes are -$51.0 million (Q1 2026), $6.9 million (Q4 2025), and $2.4 million (Q3 2025).